# Evaluating the Delivery and Effects of THC Vaping Liquids in the Bloodstream

> **NCT06334016** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Roswell Park Cancer Institute** · enrollment: 60 (estimated)

## Conditions studied

- Cannabis Dependence

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **DRUG:** Cannabis sativa Extract
- **DRUG:** Nicotine
- **DRUG:** Placebo Administration
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT06334016
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-15
- **Primary completion:** 2028-03-01
- **Final completion:** 2028-03-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06334016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06334016, "Evaluating the Delivery and Effects of THC Vaping Liquids in the Bloodstream". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06334016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*